1. 2019
  2. Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy

    Aourz, N., Serruys, A-S. K., Chabwine, J. N., Balegamire, P. B., Afrikanova, T., Edrada-Ebel, R., Grey, A. I., Kamuhabwa, A. R., Walrave, L., Esguerra, C. V., van Leuven, F., de Witte, P. A. M., Smolders, I. & Crawford, A. D., 17 Apr 2019, In : ACS Chemical Neuroscience. 10, 4, p. 1992-2003 12 p.

    Research output: Contribution to journalArticle

  3. "+ Flash Presentation" CE-MS plasma metabolomics of a mouse model for acute seizures.

    Segers, K., Zhang, W., Mangelings, D., Hankemeier, T., De Bundel, D., Vander Heyden, Y., Smolders, I., Ramautar, R. & Van Eeckhaut, A., 2019.

    Research output: Unpublished contribution to conferencePoster

  4. cOFM and MD as techniques to investigate the BBB passage of nanobodies

    Custers, M-L., Wouters, Y., Jaspers, T., Van Eeckhaut, A., De Strooper, B., Dewilde, M. & Smolders, I., 2019, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  5. cOFM and MD as techniques to investigate the BBB passage of nanobodies

    Custers, M-L., Wouters, Y., Jaspers, T., Van Eeckhaut, A., De Strooper, B., Dewilde, M. & Smolders, I., 2019, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

  6. cOFM and MD as techniques to investigate the BBB passage of nanobodies

    Custers, M-L., Wouters, Y., Jaspers, T., Van Eeckhaut, A., De Strooper, B., Dewilde, M. & Smolders, I., 2019, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

Previous 1 2 3 4 5 6 7 8 ...50 Next

ID: 177801